Vietnam Veterans Liver Fluke Cancer Study Act

Bill: 115-hr-6637
Sponsor: full_name: Rep. Zeldin, Lee M. [R-NY-1]
Introduced: 2018-07-26
Policy area: Armed Forces and National Security
Subjects: Asia

Cancer

Conflicts and wars

Congressional oversight

Government information and archives

Government studies and investigations

Health information and medical records

Veterans' medical care

Vietnam
Latest action: action_date: 2018-07-26
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2018-07-26
action_desc: Introduced in House
text: <p><b>Vietnam Veterans Liver Fluke Cancer Study Act</b></p> <p>This bill directs the Department of Veterans Affairs to conduct an epidemiological study and report to Congress on the prevalence of cholangiocarcinoma (bile duct cancer) in Vietnam era veterans. The study shall identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.</p>

tv_txt: I 115th CONGRESS 2d Session H. R. 6637 IN THE HOUSE OF REPRESENTATIVES July 26, 2018 Mr. Zeldin (for himself, Mr. King of New York , Mr. Fitzpatrick , Mr. Suozzi , and Miss Rice of New York ) introduced the following bill; which was referred to the Committee on Veterans' Affairs A BILL To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans of the Vietnam era, and for other purposes.

1. Short title This Act may be cited as the Vietnam Veterans Liver Fluke Cancer Study Act . 2. Study on the prevalence of chol­an­gio­car­ci­no­ma in veterans of the Vietnam era (a) Epidemiological study Not later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers of Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of chol­an­gio­car­ci­no­ma in veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall— (1) identify the rate of incidence of chol­an­gio­car­ci­no­ma in veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and (2) for each of the groups specified in paragraph (1), identify the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis. (b) Report to Congress Not later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing— (1) the results of the study under subsection (a); and (2) recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a). (c) Continued tracking of cholangiocarcinoma in veterans of the Vietnam era The Secretary shall track the prevalence of chol­an­gio­car­ci­no­ma in veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress as required under subsection (d). (d) Follow-Up reports The Secretary shall periodically submit to the Congress an updated report under subsection (b), as determined by the Secretary. (e) Definitions In this section: (1) The term Secretary means the Secretary of Veterans Affairs. (2) The term Vietnam era has the meaning given such term in section 101 of title 38, United States Code. (3) The term veterans of the Vietnam era has the meaning given such term in section 4211 of title 38, United States Code.